Working… Menu

Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03309462
Recruitment Status : Completed
First Posted : October 13, 2017
Last Update Posted : December 9, 2019
Information provided by (Responsible Party):
Jiayuan Sun, Shanghai Chest Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 30, 2018
Actual Study Completion Date : July 31, 2019